Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 294 shares at $11.51 ($3K) on 2023-12-27, disclosed to the SEC on 2023-12-29.
Open-market sale of $3k RLAY by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |